PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3394482-6	1988	Preincubation of PMN with low doses of thiopentone enhanced oxygen consumption in unstimulated cells as well as in response to FMLP, but not PMA.	Thiopental	39-50	formyl peptide receptor 1	Homo sapiens	127-131	
12113609-9	2002	RESULTS: FMLP and C5a-induced hydrogen peroxide production were both significantly impaired by thiopental, but not by methohexital.	Thiopental	95-105	formyl peptide receptor 1	Homo sapiens	9-13	
8958489-0	1996	Thiopentone and propofol, but not methohexitone nor midazolam, inhibit neutrophil oxidative responses to the bacterial peptide FMLP.	Thiopental	0-11	formyl peptide receptor 1	Homo sapiens	127-131	
15292650-2	2004	A suppression of the response to 50% compared to control required a 100-fold therapeutic concentration of methohexitone, while therapeutic concentrations of the thiopentone racemate led to a significant inhibition (relative fluorescence of neutrophils 0.46 +/- 0.03 compared to fMLP controls).	Thiopental	161-172	formyl peptide receptor 1	Homo sapiens	278-282	
7988581-3	1994	Pentobarbitone, phenobarbitone and thiopentone dose-dependently decreased FMLP-induced chemiluminescence and cell-free chemiluminescence.	Thiopental	35-46	formyl peptide receptor 1	Homo sapiens	74-78	
3394482-8	1988	The highest concentration of thiopentone depressed both oxygen uptake and volume/aggregation responses in FMLP-stimulated PMN.	Thiopental	29-40	formyl peptide receptor 1	Homo sapiens	106-110